CA-MRSA Infection in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome
Community-associated Staphylococcus Aureus Infections in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome
Sponsor: Sir Run Run Shaw Hospital
This observational or N/A phase trial investigates Community-Acquired Infections and Methicillin-resistant Staphylococcus Aureus and is currently ongoing. Sir Run Run Shaw Hospital leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
▶ Show 5 earlier versions
-
Mar 2019 — Nov 2020 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
May 2018 — Mar 2019 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
May 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sir Run Run Shaw Hospital
For direct contact, visit the study record on ClinicalTrials.gov .